DERMAPHARM HOLDING SE (DMP.DE) Fundamental Analysis & Valuation

FRA:DMP • DE000A2GS5D8

Current stock price

44.175 EUR
+1.52 (+3.58%)
Last:

This DMP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. DMP.DE Profitability Analysis

1.1 Basic Checks

  • DMP had positive earnings in the past year.
  • In the past year DMP had a positive cash flow from operations.
  • DMP had positive earnings in each of the past 5 years.
  • DMP had a positive operating cash flow in each of the past 5 years.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DMP's Return On Assets of 5.48% is in line compared to the rest of the industry. DMP outperforms 54.90% of its industry peers.
  • DMP's Return On Equity of 17.87% is fine compared to the rest of the industry. DMP outperforms 68.63% of its industry peers.
  • DMP has a Return On Invested Capital of 7.26%. This is comparable to the rest of the industry: DMP outperforms 50.98% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 14.61%.
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROIC 7.26%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • DMP has a Profit Margin (10.00%) which is comparable to the rest of the industry.
  • DMP's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 18.70%, DMP perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • DMP's Operating Margin has improved in the last couple of years.
  • The Gross Margin of DMP (66.57%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of DMP has grown nicely.
Industry RankSector Rank
OM 18.7%
PM (TTM) 10%
GM 66.57%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DMP.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
  • DMP has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DMP has about the same amount of shares outstanding.
  • DMP has a worse debt/assets ratio than last year.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • DMP has an Altman-Z score of 2.35. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • DMP has a Altman-Z score (2.35) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of DMP is 6.15, which is on the high side as it means it would take DMP, 6.15 years of fcf income to pay off all of its debts.
  • DMP has a Debt to FCF ratio (6.15) which is in line with its industry peers.
  • DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of DMP (1.44) is worse than 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Altman-Z 2.35
ROIC/WACC1.04
WACC7%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • DMP has a Current Ratio of 2.20. This indicates that DMP is financially healthy and has no problem in meeting its short term obligations.
  • DMP has a better Current ratio (2.20) than 72.55% of its industry peers.
  • A Quick Ratio of 1.04 indicates that DMP should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.04, DMP is in line with its industry, outperforming 54.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.04
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DMP.DE Growth Analysis

3.1 Past

  • DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.01%, which is quite impressive.
  • Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
  • The Revenue has been growing slightly by 0.11% in the past year.
  • The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.68% on average over the next years. This is quite good.
  • Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 3.04% on average per year.
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue Next Year-0.67%
Revenue Next 2Y1.53%
Revenue Next 3Y2.23%
Revenue Next 5Y3.04%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. DMP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 20.55 indicates a rather expensive valuation of DMP.
  • DMP's Price/Earnings is on the same level as the industry average.
  • DMP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.61, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 17.55, DMP is valued on the expensive side.
  • DMP's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.79, DMP is valued a bit cheaper.
Industry RankSector Rank
PE 20.55
Fwd PE 17.55
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than the industry average as 72.55% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a rather cheap valuation: DMP is cheaper than 82.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.46
EV/EBITDA 10.43
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.82
PEG (5Y)2.55
EPS Next 2Y10.93%
EPS Next 3Y10.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DMP.DE Dividend Analysis

5.1 Amount

  • DMP has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
  • DMP's Dividend Yield is a higher than the industry average which is at 1.90.
  • Compared to an average S&P500 Dividend Yield of 1.89, DMP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
  • The dividend of DMP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.76%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DMP.DE Fundamentals: All Metrics, Ratios and Statistics

DERMAPHARM HOLDING SE

FRA:DMP (3/26/2026, 5:29:48 PM)

44.175

+1.52 (+3.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-17
Earnings (Next)05-13
Inst Owners11.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.38B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target43.25 (-2.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.95%
PT rev (3m)0.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 20.55
Fwd PE 17.55
P/S 2.05
P/FCF 14.46
P/OCF 11.52
P/B 3.66
P/tB N/A
EV/EBITDA 10.43
EPS(TTM)2.15
EY4.87%
EPS(NY)2.52
Fwd EY5.7%
FCF(TTM)3.05
FCFY6.91%
OCF(TTM)3.84
OCFY8.68%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.82
PEG (5Y)2.55
Graham Number24.15
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROCE 11.89%
ROIC 7.26%
ROICexc 7.91%
ROICexgc 21.74%
OM 18.7%
PM (TTM) 10%
GM 66.57%
FCFM 14.17%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Debt/EBITDA 3.09
Cap/Depr 49.31%
Cap/Sales 3.63%
Interest Coverage 4.01
Cash Conversion 68.3%
Profit Quality 141.71%
Current Ratio 2.2
Quick Ratio 1.04
Altman-Z 2.35
F-Score7
WACC7%
ROIC/WACC1.04
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.67%
Revenue Next 2Y1.53%
Revenue Next 3Y2.23%
Revenue Next 5Y3.04%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.32%
EBIT Next 3Y19.7%
EBIT Next 5Y8.2%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%

DERMAPHARM HOLDING SE / DMP.DE Fundamental Analysis FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 4 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.


How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 20.55 and the Price/Book (PB) ratio is 3.66.


Can you provide the expected EPS growth for DMP stock?

The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 11.31% in the next year.